INTRA-CELLULAR THERAPIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.11 USD | -0.20% |
|
+2.11% | +4.87% |
Chart calendar Intra-Cellular Therapies, Inc.
5d84f1680f1e6a3d4e31dfef69ed0d.HdNQ3aA-Jj45c3otL7EY50PzvQH-4Jx9XJ8Aq4_w_W0.LLgCjJBJV2p_QStlGMMgswuX61WzhvUNPd11_9y6nhlNnwCfmQhBcwxACQ~a0fa6b10d66fe428f07cdf717500b95b
Upcoming events on Intra-Cellular Therapies, Inc.
Past events on Intra-Cellular Therapies, Inc.
| 2024-09-11 11:25 am | Baird Global Healthcare Conference |
| 2024-09-04 10:00 am | Morgan Stanley Healthcare Conference |
| 2024-08-13 12:00 pm | CG Growth Conference |
| 2024-08-07 08:30 am | Q2 2024 Earnings Call |
| 2024-08-07 07:30 am | Q2 2024 Earnings Release |
| 2024-06-18 08:30 am | Business Update Call |
| 2024-06-14 11:00 am | Annual General Meeting |
| 2024-06-11 10:00 am | Goldman Sachs Global Healthcare Conference |
| 2024-06-05 11:00 am | Jefferies Global Healthcare Conference |
| 2024-05-16 12:20 pm | BofA Securities Health Care Conference |
| 2024-05-14 10:00 am | RBC Capital Markets Global Healthcare Conference |
| 2024-05-07 08:30 am | Q1 2024 Earnings Call |
| 2024-05-07 07:30 am | Q1 2024 Earnings Release |
| 2024-04-16 08:30 am | MDD Study 501 Topline Results Call |
| 2024-03-17 | UBS Virtual CNS Day |
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-12 10:40 am | Leerink Partners Global Biopharma Conference |
| 2024-03-05 11:10 am | TD Cowen Health Care Conference |
| 2024-02-22 08:30 am | Q4 2023 Earnings Call |
| 2024-02-22 07:30 am | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 83,8 83,1 0.84% | 250 249 0.38% | 464 468 -0.81% | 667 | 917 | 1 360 |
|
EBITDA Million USD | Released Forecast Spread | -285 -284 -0.44% | -263 -276 4.73% | -159 -173 8.37% | -104 | 9,37 | 318 |
|
EBIT Million USD | Released Forecast Spread | -286 -282 -1.31% | -264 -274 3.7% | -159 -172 7.53% | -101 | 45,6 | 395 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -284 -282 -0.7% | -256 -271 5.52% | -139 -154 9.86% | -63,9 | 81,2 | 461 |
|
Net income Million USD | Released Forecast Spread | -284 -282 -0.74% | -256 -270 5.14% | -140 -155 10.02% | -64,2 | 73,5 | 400 |
|
EPS USD | Released Forecast Spread | -3,50 -3,45 -1.33% | -2,72 -2,87 5.09% | -1,46 -1,63 10.25% | -0,68 | 0,65 | 3,49 |
| Announcement Date | 01/03/22 | 01/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 71,9 66,0 8.89% | 87,9 87,0 1.04% | 95,3 92,4 3.13% | 111 107 3.72% | 126 119 5.83% | 132 136 -2.63% | 145 141 2.42% | 161 158 2.22% | 172 | 189 | 195 | 210 | 232 | 260 |
|
EBITDA Million USD | Released Forecast Spread | -55,5 -83,9 33.92% | -47,3 -71,0 33.42% | -48,3 -67,5 28.46% | -47,1 -57,2 17.75% | -29,6 -65,1 54.53% | -34,0 -50,7 32.99% | -20,8 -35,5 41.35% | -27,6 -28,1 1.8% | -29,3 | -18,7 | ||||
|
EBIT Million USD | Released Forecast Spread | -55,6 -77,3 28.06% | -47,4 -57,3 17.29% | -48,4 -60,1 19.5% | -47,2 -57,8 18.39% | -29,7 -58,1 48.89% | -34,1 -47,4 28.04% | -21,0 -34,2 38.67% | -27,7 -25,0 -10.8% | -29,5 | -23,9 | -22,1 | -12,6 | 2,76 | 21,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -53,5 -82,9 35.48% | -44,0 -58,4 24.66% | -44,0 -58,6 24.86% | -42,6 -55,5 23.16% | -24,2 -55,5 56.38% | -28,1 -42,1 33.19% | -14,9 -30,1 50.53% | -16,2 -22,3 27.48% | -20,7 | -10,3 | -13,8 | -2,31 | 13,1 | 32,2 |
|
Net income Million USD | Released Forecast Spread | -53,5 -77,3 30.74% | -44,0 -57,5 23.39% | -44,1 -60,0 26.55% | -42,8 -56,5 24.3% | -24,3 -56,5 57.04% | -28,6 -42,5 32.68% | -15,2 -31,7 51.88% | -16,2 -21,3 23.81% | -20,0 | -10,3 | -14,4 | -3,76 | 12,8 | 31,5 |
|
EPS USD | Released Forecast Spread | -0,57 -0,82 30.5% | -0,45 -0,60 25.24% | -0,46 -0,62 26.33% | -0,45 -0,59 23.89% | -0,25 -0,59 57.32% | -0,30 -0,45 33.67% | -0,16 -0,33 51.02% | -0,16 -0,21 24.17% | -0,21 | -0,14 | -0,10 | -0,07 | 0,04 | 0,20 |
| Announcement Date | 03/11/22 | 01/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | 07/05/24 | 07/08/24 | - | - | - | - | - | - |
More events
Past sector events for Intra-Cellular Therapies, Inc.
| 2024-09-09 04:05 pm | AVID BIOSERVICES, INC.: Q1 2025 Earnings Release |
| 2024-09-05 06:30 am | KALVISTA PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |
| 2024-08-30 11:56 pm | SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-30 | TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL VACCINE INC.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL ENGINEERING INC.: Q2 2024 Earnings Release |
| 2024-08-29 07:32 am | CLINUVEL PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | AIM VACCINE CO., LTD.: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ITCI Stock
- Calendar Intra-Cellular Therapies, Inc.